Quoin Pharmaceuticals at Risk of Nasdaq Delisting Amidst Financial Challenges

TipRanksNov 9 14:01

Maxim Group Maintains Quoin Pharmaceuticals(QNRX.US) With Buy Rating, Maintains Target Price $2

Futu NewsNov 9 02:31 · Ratings

Promising Developments and Financial Stability Propel Quoin Pharmaceuticals' Buy Rating

TipRanksNov 9 01:35 · Ratings

Quoin Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 9 00:29 · Announcements

Quoin Pharmaceuticals GAAP EPS of -$0.47 Misses by $0.01

Seeking AlphaNov 7 21:26

Quoin Pharmaceuticals 3Q Loss/Shr 47c >QNRX

Dow JonesNov 7 21:07